Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis

被引:0
|
作者
Mojca Zajc Avramovič
Nataša Toplak
Meta Accetto
Maruša Debeljak
Lara Lusa
Vita Dolžan
Tadej Avčin
机构
[1] Paediatric Clinic of University Clinical Centre Ljubljana,Institute for Biochemistry
[2] Institute for Biostatistics and Medical Informatics,undefined
[3] Medical Faculty,undefined
关键词
Single Nucleotide Polymorphism; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Single Nucleotide Polymorphism; Severe Adverse Event;
D O I
10.1186/1546-0096-12-S1-P26
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Genetic determinants for methotrexate response in juvenile idiopathic arthritis
    Pastore, Serena
    Stocco, Gabriele
    Favretto, Diego
    De Ludicibus, Sara
    Taddio, Andrea
    d'Adamo, Pio
    Malusa, Noelia
    Addobbati, Riccardo
    Decorti, Giuliana
    Lepore, Loredana
    Ventura, Alessandro
    [J]. FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [2] EFFICACY AND TOLERANCE OF METHOTREXATE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Fazaa, A.
    Rouatbi, F.
    Miladi, S.
    Ouenniche, K.
    Souabni, L.
    Kassab, S.
    Chekili, S.
    Ben Abdelghani, K.
    Laatar, A.
    [J]. RHEUMATOLOGY, 2021, 60
  • [3] Methotrexate in the treatment of juvenile idiopathic arthritis
    Seeliger, S
    Niehues, T
    Harms, E
    Frosch, M
    Roth, J
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2002, 150 (04) : 452 - 459
  • [4] Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
    Ana Carolina Da Silva
    A Farias
    Nailu Sinicato
    R Veloso
    Roberto Marini
    Simone Appenzeller
    [J]. Pediatric Rheumatology, 12 (Suppl 1)
  • [5] TREATMENT WITH METHOTREXATE PLUS LEFLUNOMIDE FOR JUVENILE IDIOPATHIC ARTHRITIS
    Quesada-Masachs, E.
    Castillo, M.
    Avila, G.
    Modesto, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 996 - 996
  • [6] EFFICACY AND SAFETY OF SECUKINUMAB TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
    Kriulin, I.
    Alexeeva, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Krekhova, E.
    Shingarova, M.
    Alshevskaya, A.
    Moskalev, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 485 - 485
  • [7] Efficacy and Safety of Methotrexate in Oligoarticular Persistent Juvenile Idiopathic Arthritis
    Schmeling, Heinrike
    Foeldvari, Ivan
    Horneff, Gerd
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S59 - S59
  • [8] Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis
    Yanagimachi, Masakatsu
    Naruto, Takuya
    Hara, Takuma
    Kikuchi, Masako
    Hara, Ryoki
    Miyamae, Takako
    Imagawa, Tomoyuki
    Mori, Masaaki
    Kaneko, Tetsuji
    Morita, Satoshi
    Goto, Hiroaki
    Yokota, Shumpei
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 237 - 243
  • [9] Genetic polymorphisms in the folate pathway are associated with methotrexate efficacy and adverse effects in Juvenile Idiopathic Arthritis
    Heijstek, Marloes W.
    Wulffraat, Nico M.
    Eken, Yusuf
    Pluijm, Saskia M. F.
    Rademaker, Karin M. A.
    de Jonge, Robert
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S499 - S499
  • [10] Recommendations for the use of methotrexate in patients with juvenile idiopathic arthritis
    CaIvo, I.
    Anton, J.
    Lopez Robledillo, J. C.
    de Inocencio, J.
    Gamir, M. L.
    Merino, R.
    Lacruz, L.
    Camacho, M.
    Rua, M. J.
    Bustabad, S.
    Diaz Cordoves-Rego, G.
    [J]. ANALES DE PEDIATRIA, 2016, 84 (03): : 177 - 177